MD · NYSE · Medical - Care Facilities

Pediatrix Medical Group (MD)

Staffs neonatal, maternal-fetal, obstetrical, and pediatric specialty care across US hospitals and practices.

$26.02
vs last close−0.33 (−1.25%)
Loading prices…

Pediatrix Medical Group, Inc.MD
Health Care

Provides hospital-based neonatal and pediatric physician services plus maternal-fetal and obstetrical care, earning patient-service revenue from insurers and government programs and administrative fees from hospitals. Neonatal care is the largest practice line, and operations depend on hospital contracts, clinician staffing, patient volumes, and reimbursement rules.

Provides neonatal, maternal-fetal and obstetrical, pediatric intensive-care, hospitalist, and pediatric surgical physician services across 37 US states. Affiliated clinicians staff and manage hospital units—especially neonatal intensive care units—and deliver office-based maternal-fetal care, while central infrastructure supports recruiting, credentialing, scheduling, billing, collections, clinical data, and quality programs. Patient-service fees from insurers and government programs drive most revenue, supplemented by administrative fees from hospital partners.

Neonatal care is the largest practice line, tying demand to births and medically complex deliveries. The network is concentrated in a handful of states, led by Texas, and relies on hospital contracts, clinician recruitment and retention, patient volumes, and effective revenue-cycle operations. Reimbursement is shaped by commercial payor contracts, Medicaid rates, the No Surprises Act, and other federal and state healthcare rules.

Company facts

CEOMark S. Ordan
ListedSep 20, 1995
ExchangeNYSE
HeadquartersSunrise, FL
CountryUnited States
Employees4,280
CIK0000893949
ISINUS58502B1061

Market cap$2.16B
EPS (ttm)$2.09
P/E (ttm)12.61
ROE19.9%
P/B2.46
P/S1.11
Dividend yieldDiv yield
Beta0.44vs XLV 0.62

Price target$28.00+6.3%Average of 33 analysts
ConsensusHold18 of 33 analysts
Ratings

Target rangeAs of Sep 22, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 19, 2026JefferiesDowngrade
Rating: NeutralTarget: $27
Rating: HoldTarget: $28
Aug 6, 2026UBSReiterate
Rating: Target: $25
Rating: NeutralTarget: $28
Aug 5, 2026Deutsche BankReiterate
Rating: Target: $19
Rating: HoldTarget: $25
Jul 14, 2026Truist FinancialTarget
Target: $21
Target: $28
May 12, 2026UBSReiterate
Rating: Target: $22
Rating: NeutralTarget: $25

Next report
Nov 2, 26
in 40 days
EPS estimate
$0.63
Revenue estimate
$498.2M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.51$0.33$0.53$0.67$0.50$0.44$0.63Pending
Estimate$0.37$0.25$0.42$0.46$0.53$0.37$0.59$0.63
Surprise+37.8%+32.0%+26.2%+45.7%−5.7%+18.9%+6.6%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$502.4M$458.4M$468.8M$492.9M$493.8M$476.2M$487.8MPending
Estimate$473.3M$459.7M$473.7M$486.2M$486.2M$465.8M$478.5M$498.2M
Surprise+6.1%−0.3%−1.0%+1.4%+1.6%+2.2%+1.9%
Estimate$0.63
ReportedDue Nov 2, 2026
Estimate$498.2M
ReportedDue Nov 2, 2026
View details

Debt to equity70.40%
Current ratio131.60%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$511.2M$502.4M$458.4M$468.8M$492.9M$493.8M$476.2M$487.8M
Net income$19.4M$30.5M$20.7M$39.3M$71.7M$33.7M$29.6M$39.8M
Net margin3.8%6.1%4.5%8.4%14.5%6.8%6.2%8.2%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$33.8M$39.3M$32.1M$59.9M$68.1M$54.7M$46.6M$56.9M
YoY growth−16.0%Turned profit+102.0%Turned profit+101.2%+39.1%+45.1%−4.9%

Balance sheet, Jun 30, 2026Cash & short-term investments $404.2M · Total debt $620.0M · Total assets $2.13B · Shareholders' equity $881.0M

Revenue
$487.8M
Operating income
$56.9M
Net income
$39.8M
View details

No dividends on record.

Institutions≈ 103.80%84.34M shares
306 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail
Insiders1.32%1.07M shares
13 holders · as of Sep 14, 2026
Adds to105.12%

81.25M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

These groups come from separate filings that can overlap, so they add to 105.12%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Institution
16.88%13.71Mas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
7.37%5.99Mas of Jun 30, 2026
Dimensional Fund Advisors LPInstitution
5.19%4.22Mas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
4.46%3.62Mas of Jun 30, 2026
State Street CorpInstitution
4.35%3.53Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
May 13, 2026Shirley A. Weisdirector−36,028$23.75
Dec 15, 2025Mark S. Ordandirector, officer: Chief Executive Officer−23,000$22.41
Nov 17, 2025Michael A. Ruckerdirector−10,478$23.00
Nov 6, 2025Laura A. Linynskydirector−10,000$21.65
View details

Compare

CompanyPriceChange
Pediatrix Medical Group$26.02−1.25%$2.16B12.611.11.1+4.0%
HCA Healthcare$442.30+0.95%$94.85B14.714.51.2+8.7%
Tenet Healthcare$261.14−0.35%$21.10B10.112.51.0+6.8%
Universal Health Services$184.12+2.69%$10.85B7.48.00.6+8.3%
Community Health Systems$3.08+1.82%$425.8M0.0−9.8%
UnitedHealth Group$371.23−0.46%$338.69B24.017.40.8+0.4%
Privia Health$19.03−2.23%$2.45B89.749.51.0+21.4%
Median14.714.50.9+7.5%